This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Gilead Sciences, Inc.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Marcus Jerling
Introduction
Marcus Jerling is a notable inventor based in Bromma, Sweden. He has made significant contributions to the field of diabetes treatment through his innovative patent. His work focuses on improving the health outcomes of patients suffering from diabetes and related cardiovascular diseases.
Latest Patents
Marcus Jerling holds a patent for a method of treating diabetes. This method provides techniques for lowering plasma levels of HbA1c in diabetic, pre-diabetic, or non-diabetic patients who are also suffering from at least one cardiovascular disease. Additionally, it aims to slow or delay the development of hyperglycemia in these patients.
Career Highlights
Jerling is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company. His role at Gilead allows him to work on groundbreaking research and development projects that aim to improve patient care and treatment options.
Collaborations
Throughout his career, Marcus has collaborated with esteemed colleagues, including Andrew A. Wolff and Brent Blackburn. These collaborations have further enhanced the impact of his work in the medical field.
Conclusion
Marcus Jerling's innovative approach to diabetes treatment exemplifies the importance of research and development in healthcare. His contributions are paving the way for better management of diabetes and related conditions.